The Impact Of The Coronavirus (Covid-19) Pandemic Is Expected To Limit The Growth Of The Global Antibody Drug Conjugates Market

 

Antibody Drug Conjugates

ADCs are highly targeted biopharmaceutical drugs that combine monoclonal antibodies specific for surface antigens found on specific tumour cells with highly effective anticancer agents linked by chemical linkers. Antibody-drug conjugates, in a nutshell, deliver "deactivated" cytotoxins to cancer cells. Once inside the tumour cell – internalisation – the cytotoxin re-establishes its full cytotoxic – cancer-killing – activity. As a result, cell death is rapid. There are thousands of cellular toxins derived from natural sources or chemically synthesised, but only a few of them are suitable as components in an antibody-drug conjugate (ADCs). Early ADCs were developed with clinically approved chemotherapeutic drugs like doxorubicin and methotrexate.

As a result of cancer screening discontinuation and postponed hospital visits, the impact of the coronavirus (COVID-19) pandemic is expected to limit the growth of the global Antibody Drug Conjugates Market. According to a July 2021 article published in The Lancet Oncology, an ambidirectional cohort study was conducted at 41 cancer centres in India that were members of the National Cancer Grid of India to compare oncology service provision between March 1, 2020 and May 31, 2020, with the same time period in 2019. The findings of the cohort study revealed that the COVID-19 pandemic has a significant impact on cancer care. All aspects of care were reduced during the pandemic, including screening, diagnosis, treatment, palliative care, and follow-up.

Increased cancer prevalence worldwide, unhealthy urban lifestyles, and increased consumption of tobacco and alcohol across geographies are major cancer risk factors. "The number of people living beyond cancer diagnosis is expected to reach approximately 19 million by 2024," according to the National Cancer Institute. During the study period, the Antibody Drug Conjugates Market is expected to be driven by an increase in demand for cost-effective and high-quality cancer treatment. The rising prevalence of breast cancer is expected to drive the global antibody drug conjugates market forward. According to the Centers for Disease Control and Prevention (CDC), the United States reported 254,744 new cases of breast cancer in women in 2018, with 42,465 women dying from the disease. Furthermore, in 2018, 127 new cases of breast cancer were diagnosed in 100,000 women, and 20 women died as a result of the disease.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Image
  Scottish Whisky Market The Scottish Whisky Market is a captivating landscape that has been evolving and transforming over the years. It is a world of tradition, craftsmanship, and heritage, where every drop of whisky tells a story. The history of Scottish whisky traces back centuries, with the earliest records dating back to the 15th century. Whisky production initially started in monasteries, where monks distilled spirits for medicinal purposes. Over time, whisky production moved from monastic settings to farms and then to commercial distilleries. This transition marked the beginning of an industry that would become synonymous with Scotland. Scottish Whisky Market Was Valued At US$ 4.97 Bn In 2018, And It Is Expected To Reach US$ 7.89 Bn By The End Of 2027, Exhibiting A CAGR Of 5.3% During The Forecast Period (2019 To 2027). One of the defining characteristics of the Scottish Whisky Market is its adherence to traditional production methods. Scotch whisky is made from malted b
Read more

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides

Image
Monochloroacetic Acid (MCAA) Market The Monochloroacetic Acid (MCAA) Market is estimated to be valued at USD 676.52 Million in 2022 and is expected to exhibit a CAGR of 7.03% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Monochloroacetic Acid (MCAA) Market is driven by the increasing demand for surfactants and herbicides in several industries such as agriculture, pharmaceuticals, textiles, and personal care. MCAA is extensively used in the production of surfactants, herbicides, and carboxymethyl cellulose (CMC), which are essential in various applications. These applications include detergents, agrochemicals, pharmaceuticals, dyes, and cosmetics, among others. The versatile properties of MCAA, such as its ability to act as a raw material in the production of herbicides and surfactants, make it highly desirable in the market. Market Dynamics: The Monochloroacetic Acid (MCAA) Market is driven by two k
Read more